In the News
GCI Researcher Leads Terry Fox Research Institute-Funded Program on Tumor-Driven Immunosuppression
The Gynecologic Cancer Initiative is delighted to share that GCI Researcher, Dr. Julian J. Lum, and his team were recently awarded with the 2023 Terry Fox New Frontiers Program Project Grant to support their research on tumour-driven immunosuppression.
Their work seeks to investigate how the by-products of tumor cell metabolism can lead to immune cell inactivation– a problem that often renders immunotherapy ineffective on hard-to-treat tumors, including ovarian cancer.
2023 Gynecologic Cancer Research Combined Grants Recipients
Earlier this year, the GCI launched a funding competition to support gynecologic cancer research. The GCI would like to congratulate this year’s wonderful recipients of the Carraressi, Division of Gynecologic Oncology, and Sumiko Kobayashi Research Award.
These grants are designed to support early and mid-career researchers, provide critical review, with rapid turn-around and constructive feedback, and funding for proposals that may not be eligible to receive funding at the national level.
The Impact of the ProMisE Endometrial Carcinoma Molecular Classifier
Dr. Jessica McAlpine and Dr. Amy Jamieson were recently interviewed by Imagia Canexia Health. Dr. McAlpine and Dr. Jamieson, and their team have been working to refine and expand the ProMisE molecular classification system as to better direct patient care. In this interview they discussed the development of ProMisE, its clinical impact, and the significance of the team’s recent findings on NSMP, the most common molecular type of endometrial cancer.
Read the GCI Blog!
The GCI launched a blog focused on knowledge translation and science communications. This platform intends to make information about gynecologic cancers and the gynecoloic cancer research in BC more accessible to the general population.